• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙胺嘧啶-磺胺多辛(Fansidar)导致的致命性肝坏死。

Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).

作者信息

Zitelli B J, Alexander J, Taylor S, Miller K D, Howrie D L, Kuritsky J N, Perez T H, Van Thiel D H

出版信息

Ann Intern Med. 1987 Mar;106(3):393-5. doi: 10.7326/0003-4819-106-3-393.

DOI:10.7326/0003-4819-106-3-393
PMID:2949680
Abstract

Pyrimethamine-sulfadoxine has been associated with severe and fatal cutaneous reactions as well as transient liver damage. We report the case of a patient who died of progressive hepatic failure caused by pyrimethamine-sulfadoxine administration. In addition, we summarize reports made to the Food and Drug Administration since 1982 that focus on hepatotoxic reactions to pyrimethamine-sulfadoxine. We suggest that fatal hepatic injury can occur after treatment with pyrimethamine-sulfadoxine and that physicians who prescribe the drug should be aware of this possibility.

摘要

乙胺嘧啶-磺胺多辛与严重及致命的皮肤反应以及短暂性肝损伤有关。我们报告了一例因使用乙胺嘧啶-磺胺多辛导致进行性肝衰竭而死亡的患者病例。此外,我们总结了自1982年以来向美国食品药品监督管理局提交的关于乙胺嘧啶-磺胺多辛肝毒性反应的报告。我们建议,使用乙胺嘧啶-磺胺多辛治疗后可能会发生致命性肝损伤,开具该药物的医生应意识到这种可能性。

相似文献

1
Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).乙胺嘧啶-磺胺多辛(Fansidar)导致的致命性肝坏死。
Ann Intern Med. 1987 Mar;106(3):393-5. doi: 10.7326/0003-4819-106-3-393.
2
Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).与乙胺嘧啶和磺胺多辛(Fansidar)预防用药相关的致命多系统毒性。
Br Med J (Clin Res Ed). 1985 Jan 12;290(6462):113-4. doi: 10.1136/bmj.290.6462.113-a.
3
[Acute hepatitis following administration of fansidar].[服用 Fansidar 后出现的急性肝炎]
Schweiz Med Wochenschr. 1990 Feb 17;120(7):221-5.
4
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.使用乙胺嘧啶-磺胺多辛(Fansidar)预防疟疾的美国旅行者中出现的严重皮肤反应。
Am J Trop Med Hyg. 1986 May;35(3):451-8. doi: 10.4269/ajtmh.1986.35.451.
5
[Fansidar-induced maculopathy and dermatitis exfoliativa].[乙胺嘧啶-磺胺多辛引起的黄斑病变和剥脱性皮炎]
Tidsskr Nor Laegeforen. 1987 May 20;107(14):1231-2.
6
Erythroderma resembling sézary syndrome after treatment with Fansidar and chloroquine.使用 Fansidar 和氯喹治疗后出现类似 Sézary 综合征的红皮病。
Br Med J (Clin Res Ed). 1986 Apr 26;292(6528):1107-8. doi: 10.1136/bmj.292.6528.1107-a.
7
Systemic reaction to pyrimethamine-sulfadoxine.对乙胺嘧啶-磺胺多辛的全身反应。
J Fam Pract. 1986 Apr;22(4):375-6.
8
Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. Fansidar的不良反应及其预防疟疾使用的最新建议。
MMWR Morb Mortal Wkly Rep. 1985 Jan 4;33(51-52):713-4.
9
Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).乙胺嘧啶-磺胺多辛(Fansidar)诱发嗜酸性粒细胞性肺炎患者的磺胺多辛特异性淋巴细胞转化
Thorax. 1989 Apr;44(4):307-9. doi: 10.1136/thx.44.4.307.
10
Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.《发病率与死亡率周报》资讯。甲氟喹的不良反应及其预防疟疾使用的最新建议。
JAMA. 1985 Jan 25;253(4):483.

引用本文的文献

1
Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system.儿童肝损伤:基于食品药品监督管理局不良事件报告系统的可疑药物信号分析。
BMC Pediatr. 2023 Sep 28;23(1):492. doi: 10.1186/s12887-023-04097-9.
2
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.在塞内加尔,由地区卫生服务机构向10岁以下儿童提供磺胺多辛-乙胺嘧啶加阿莫地喹进行季节性疟疾化学预防(SMC)的安全性:一项阶梯式楔形整群随机试验的结果
PLoS One. 2016 Oct 20;11(10):e0162563. doi: 10.1371/journal.pone.0162563. eCollection 2016.
3
Hepatotoxicity of antibacterials: Pathomechanisms and clinical.抗菌药物的肝毒性:发病机制与临床。
Infection. 2010 Feb;38(1):3-11. doi: 10.1007/s15010-009-9179-z. Epub 2010 Jan 27.
4
Why prevent, diagnose and treat congenital toxoplasmosis?为什么要预防、诊断和治疗先天性弓形虫病?
Mem Inst Oswaldo Cruz. 2009 Mar;104(2):320-44. doi: 10.1590/s0074-02762009000200029.
5
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.周效磺胺/乙胺嘧啶的安全性与毒性:对孕期疟疾预防中使用间歇性预防治疗的启示
Drug Saf. 2007;30(6):481-501. doi: 10.2165/00002018-200730060-00003.
6
Antimalarial drug toxicity: a review.抗疟药毒性:综述
Drug Saf. 2004;27(1):25-61. doi: 10.2165/00002018-200427010-00003.
7
Adverse effects of antimalarials. An update.抗疟药的不良反应。最新情况
Drug Saf. 1993 Apr;8(4):295-311. doi: 10.2165/00002018-199308040-00004.